News
Medtronic has raised its fiscal year 2026 (FY26) profit outlook to 4.5%, up from a previous target of 4%, amid strong growth ...
With OpenAI-backed startup Merge Labs poised to develop brain computer interface (BCI) technologies, leadership in the space ...
Merit Medical Systems has enrolled the first subject in the multi-centre, prospective trial, WRAP North America registry, ...
NeuroOne has obtained 510(k) clearance from the FDA for its OneRF trigeminal nerve ablation system to treat facial pain.
Natera's ctDNA assay Signatera improved survival outcomes for patients with MRD-positive muscle-invasive bladder cancer (MIBC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results